Folosim cookie-uri pentru a îmbunătăți experiența pe site. Pentru detalii, citește Politica de confidențialitate.

HRT provider censured by UK regulator for ‘systemic failures’ that put patients at risk

22.04.2026 21:18 | The Guardian World

The drug industry’s self-regulatory body criticised Theramex for ‘alarming’ compliance issuesOne of the biggest producers of hormone replacement therapy has been censured by regulators for “systemic failures” that put patient safety in jeopardy.Theramex, the UK producer of HRT drugs Evorel and Intrarosa was found to have breached fundamental compliance standards including not updating crucial prescribing information – in some cases for several years – and not making it clear that a drug must not be used during pregnancy. Continue reading...

🔗 Citește articolul complet pe The Guardian World